Enovix Corp Files 8-K Report
Ticker: ENVX · Form: 8-K · Filed: 2025-07-28T00:00:00.000Z
Sentiment: neutral
Topics: regulatory-filing, 8-k
Related Tickers: ENVX
TL;DR
Enovix filed an 8-K on 7/28/25, standard update, no major news yet.
AI Summary
On July 28, 2025, Enovix Corporation filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or new material events were detailed in the provided excerpt, but it indicates a standard regulatory filing.
Why It Matters
This filing serves as a public record of significant corporate events or financial updates for Enovix Corporation, providing transparency to investors and the market.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report without immediate disclosed material changes or financial impacts.
Key Players & Entities
- Enovix Corporation (company) — Registrant
- 0001828318-25-000271 (document_id) — Accession Number
- July 28, 2025 (date) — Date of Report
- 3501 W Warren Avenue Fremont, California 94538 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Enovix Corporation?
The filing is for "Other Events" and "Financial Statements and Exhibits," indicating a standard regulatory update.
On what date was this 8-K report filed?
The report was filed on July 28, 2025.
What is Enovix Corporation's principal executive office address?
The address is 3501 W Warren Avenue, Fremont, California 94538.
What is the Commission File Number for Enovix Corporation?
The Commission File Number is 001-39753.
Does the provided excerpt detail any specific new financial results or material events?
No, the provided excerpt of the 8-K filing does not detail specific new financial results or material events.
From the Filing
0001828318-25-000271.txt : 20250728 0001828318-25-000271.hdr.sgml : 20250728 20250728170300 ACCESSION NUMBER: 0001828318-25-000271 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250728 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250728 DATE AS OF CHANGE: 20250728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enovix Corp CENTRAL INDEX KEY: 0001828318 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing EIN: 853174357 FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39753 FILM NUMBER: 251156313 BUSINESS ADDRESS: STREET 1: 3501 W. WARREN AVENUE CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 510 695-2350 MAIL ADDRESS: STREET 1: 3501 W. WARREN AVENUE CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: Rodgers Silicon Valley Acquisition Corp DATE OF NAME CHANGE: 20201014 8-K 1 envx-20250728.htm 8-K envx-20250728 0001828318 False 0001828318 2025-07-28 2025-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter)   Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 3501 W Warren Avenue Fremont , California   94538 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: ( 510 ) 695-2350 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ENVX The Nasdaq Global Select Market Warrants, each exercisable for one share of Common Stock at an exercise price of $8.75 per share ENVXW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01 Other Events. On July 28, 2025, Enovix Corporation, a Delaware corporation (the “Company”), issued a press release announcing that the price of its common stock had exceeded $10.50 for five trading days and that it was reserving the right to set an Alternate Expiration Date (defined in the Warrant Agreement) for the warrants. The warrants were distributed by the Company on July 21, 2025 (the “Warrants”) pursuant to the terms of the previously announced warrant dividend distribution and the Warrant Agreement dated July 21, 2025 between the Company and Computershare Trust Company, N.A. as Warrant Agent (the “Warrant Agreement”). The for